EGFR-IN-8, a dual inhibitor targeting both EGFR and c-Met, shows potential as a promising candidate for further development in treating EGFR TKI-resistant NSCLC.
Molecular Weight:
662.02
Purity:
97.45%
CAS Number:
[2407957-87-1]
Formula:
C32H23ClF3N7O4
Target:
c-Met/HGFR|||EGFR
T11162
* VAT and and shipping costs not included. Errors and price changes excepted